U-Neuron Biomedical Inc(TW:6973)
NT$54.89+0.10 (+0.18%)
TW:6973
U-Neuron Biomedical Inc financials statements
NT$54.89
At close:+0.10 (+0.18%)
U-Neuron Biomedical Inc (6973) Income Statement
U-Neuron Biomedical Inc Income Statement
Last quarter (Q2 2026), U-Neuron Biomedical Inc's total revenue was NT$56.04M, an increase of 169.42% from the same quarter last year. In Q2, U-Neuron Biomedical Inc's net income was NT$-28.69M. See U-Neuron Biomedical Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 82.66M | NT$ 46.21M | NT$ 27.02M | NT$ 26.79M | NT$ 28.42M | |
| NT$ 55.39M | NT$ 37.93M | NT$ 21.56M | NT$ 21.58M | NT$ 23.93M | |
| NT$ 120.57M | NT$ 106.89M | NT$ 111.88M | NT$ 61.35M | NT$ 39.00M | |
| Depreciation and Amortization | NT$ 14.52M | NT$ 8.25M | NT$ 6.96M | NT$ 6.53M | NT$ 1.64M |
| NT$ -50.66M | NT$ -51.45M | NT$ -77.87M | NT$ -36.53M | NT$ -9.62M | |
| NT$ -65.18M | NT$ -68.96M | NT$ -90.32M | NT$ -43.68M | NT$ -15.07M | |
| NT$ 9.89M | NT$ 8.99M | NT$ 5.43M | NT$ 505.00K | NT$ 3.81M | |
| NT$ -55.29M | NT$ -59.97M | NT$ -84.89M | NT$ -43.17M | NT$ -11.26M | |
| NT$ -55.29M | NT$ -59.97M | NT$ -84.89M | NT$ -43.17M | NT$ -11.26M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -1.42 | NT$ -1.76 | NT$ -3.21 | NT$ -2.70 | NT$ -0.99 |
| Diluted EPS | NT$ -1.42 | NT$ -1.76 | NT$ -3.21 | NT$ -2.70 | NT$ -0.99 |
| Weighted Average Shares Outstanding | 38.94M | 29.55M | 26.46M | 15.99M | 11.37M |
| Weighted Average Shares Outstanding (Diluted) | 38.94M | 29.55M | 26.46M | 15.99M | 11.37M |
Currency in TWD

